Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort | Zendy

Georgios Papadakis | Zendy; Didier Hans | Zendy; Elena González Rodríguez | Zendy; Péter Vollenweider | Zendy; Gérard Waeber | Zendy; Pedro MarquesVidal | Zendy; Olivier Lamy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort

Author(s) -

Georgios Papadakis,

Didier Hans,

Elena González Rodríguez,

Péter Vollenweider,

Gérard Waeber,

Pedro MarquesVidal,

Olivier Lamy

Publication year - 2018

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2017-02449

Subject(s) - medicine , confounding , lean body mass , body mass index , cohort , sarcopenia , menopause , dual energy x ray absorptiometry , cohort study , endocrinology , adipose tissue , sarcopenic obesity , body weight , osteoporosis , bone mineral

After menopause, fat mass (FM) and visceral adipose tissue (VAT) increase and nonbone lean body mass (LBM) decreases. Whether menopausal hormone therapy (MHT) reverses these changes remains controversial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research